Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance

Venu Thatikonda(Boehringer Ingelheim (Austria)), Marco H. Hofmann(Boehringer Ingelheim (Austria))
Nature Cancer
August 5, 2024
Cited by 45


Related Papers